CompuMed (OTCMKTS:CMPD) Stock Price Down 0.3% – What’s Next?

CompuMed Inc. (OTCMKTS:CMPDGet Free Report)’s stock price was down 0.3% during mid-day trading on Wednesday . The stock traded as low as $6.00 and last traded at $6.70. 1,092 shares changed hands during mid-day trading, an increase of 33% from the average daily volume of 818 shares. The stock had previously closed at $6.72.

CompuMed Stock Up 0.7%

The company has a debt-to-equity ratio of 0.12, a current ratio of 2.37 and a quick ratio of 2.34. The firm has a market capitalization of $8.98 million, a P/E ratio of -45.00 and a beta of -0.47. The business has a 50 day moving average price of $6.38 and a 200 day moving average price of $5.82.

CompuMed (OTCMKTS:CMPDGet Free Report) last issued its quarterly earnings results on Monday, May 11th. The company reported ($0.06) EPS for the quarter. The business had revenue of $2.03 million for the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Featured Articles

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.